HomeNewscoronavirusCOVID-19 pandemic: Gujarat records one of the lowest recovery rates, second highest number of cases after Maharashtra

COVID-19 pandemic: Gujarat records one of the lowest recovery rates, second highest number of cases after Maharashtra

Gujarat currently accounts for about 11% of the burden of COVID-19 infections in India. On the other hand, Maharashtra (with 5,652 cases) makes up about 26%, while Delhi another 10.35%.

April 23, 2020 / 22:02 IST
Story continues below Advertisement
Representative image
Representative image

The number of COVID-19 cases in India has crossed 21,000, with Maharashtra still reporting the highest number of cases. On April 22, Gujarat became the state with the second-highest number of reported infections, surpassing Delhi by a significant margin

As per the day's 5 pm update by the Ministry of Health and Family Welfare, the number of reported COVID-19 cases in Gujarat stands at 2,407, of which 179 have been cured, discharged, or migrated. The death toll in the state is at 103.

Story continues below Advertisement

To put this in context, the total number of COVID-19 cases in India at the time of filing this story is 21,700, of which 16,689 are active cases while 4,325 people have been cured and 686 people have lost their lives.

This means that Gujarat currently accounts for about 11 percent of the burden of COVID-19 infections in India. On the other hand, Maharashtra (with 5,652 cases) makes up about 26 percent, while Delhi another 10.35 percent of the total coronavirus positive cases in the country.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show